文献速递肝病消化道肿瘤与早癌

单区域样本评估肝细胞癌肿瘤免疫微环境的可靠性

Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma.
PubMed 文献 · J Hepatol · 2019-10-18

该前瞻性研究对12例肝细胞癌患者的13个肿瘤进行多区域采样,通过免疫组化和RNA测序评估肿瘤免疫微环境,采用马氏距离分析区域内相似性。结果显示约60-70%的肿瘤单区域样本可可靠代表整体免疫微环境,免疫组化与RNA测序一致性达83.3%。

要点

  • 约60-70%的肝细胞癌患者单区域样本可可靠评估肿瘤免疫微环境。
  • 免疫组化与RNA测序评估肿瘤内免疫微环境相似性的 concordance 率为83.3%。
  • 多区域采样显示部分肝细胞癌存在肿瘤免疫微环境异质性。

核心结论

  • 单区域肿瘤样本对约60-70%的肝细胞癌患者可可靠评估肿瘤免疫微环境。

研究设计与样本

  • 前瞻性研究,对12例患者新切除的13个肿瘤进行多区域采样,每个肿瘤中位6个样本(范围3-12)。
  • 肿瘤中位直径9 cm(范围3-16 cm),采用免疫组化检测PD-L1、CD4、CD8、CD20、FoxP3、DC-LAMP、CD68、MPO及三级淋巴结构,部分样本行RNA测序。
  • 通过多变量马氏距离分析评估肿瘤内免疫微环境相似性。

主要发现

  • 9个(69.2%)肿瘤所有区域PD-L1表达一致。
  • 13个免疫组化分析肿瘤中8个(61.5%)显示肿瘤内所有区域马氏距离较窄;12个RNA测序肿瘤中8个(66.7%)马氏距离较窄。
  • 免疫组化与RNA测序评估肿瘤内免疫微环境相似性的一致率为83.3%(10/12)。

临床怎么用

  • 对于晚期肝细胞癌患者,单区域活检样本在约60-70%情况下可代表整体肿瘤免疫微环境,支持其用于临床评估。

局限性

  • 样本量较小(12例患者,13个肿瘤),结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Intratumor heterogeneity has frequently been reported in patients with hepatocellular carcinoma (HCC). Thus, the reliability of single-region tumor samples for evaluation of the tumor immune microenvironment is also debatable. We conducted a prospective study to analyze the similarity in tumor immune microenvironments among different regions of a single tumor. METHODS: Multi-region sampling was performed on newly resected tumors. The tumor immune microenvironment was evaluated by immunohistochemical staining of PD-L1, CD4, CD8, CD20, FoxP3, DC-LAMP (or LAMP3), CD68, MPO, and tertiary lymphoid structures (TLSs). PD-L1 expression was manually quantified according to the percentage of PD-L1-stained tumor or stromal cells. The densities (number/mm2) of immune cells and the number of TLSs per sample were determined by whole-section counting. RNA-sequencing was applied in selected samples. Similarities in tumor immune microenvironments within each tumor were evaluated by multivariate Mahalanobis distance analyses. RESULTS: Thirteen tumors were collected from 12 patients. The median diameter of tumors was 9 cm (range 3-16 cm). A median of 6 samples (range 3-12) were obtained from each tumor. Nine (69.2%) tumors exhibited uniform expression of PD-L1 in all regions of the tumor. Out of 13 tumors analyzed by immunohistochemical staining, 8 (61.5%) tumors displayed a narrow Mahalanobis distance for all regions within the tumor; while 8 (66.7%) of the 12 tumors analyzed by RNA-sequencing displayed a narrow Mahalanobis distance. Immunohistochemistry and RNA-sequencing had a high concordance rate (83.3%; 10 of 12 tumors) for the evaluation of similarities between tumor immune microenvironments within a tumor. CONCLUSIONS: A single-region tumor sample might be reliable for the evaluation of tumor immune microenvironments in approximately 60-70% of patients with HCC. LAY SUMMARY: Heterogeneity in the regional immune microenvironments of tumors has been reported in patients with hepatocellular carcinoma. This heterogeneity could be an obstacle when trying to reliably evaluate the immune microenvironment of an entire tumor using only a single-region tumor sample, which may be the only option in patients with more advanced disease. Our study utilized both immunohistochemical and transcriptomic analyses to demonstrate that a single-region sample is reliable for evaluation of tumor immune microenvironments in 60-70% of patients with hepatocellular carcinoma.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Shen YC, Hsu CL, Jeng YM, et al. Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma. J Hepatol. 2019. PMID: 31634533. doi:10.1016/j.jhep.2019.09.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。